|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/16 |
| (11) | Number of the document | 1814573 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05824723.0 |
| Date of filing the European patent application | 2005-10-31 | |
| (97) | Date of publication of the European application | 2007-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/039226 |
| Date | 2005-10-31 |
| (87) | Number | WO 2006/050247 |
| Date | 2006-05-11 |
| (30) | Number | Date | Country code |
| 623342 P | 2004-10-29 | US |
| (72) |
DEFREES, Shawn, US
|
| (73) |
ratiopharm GmbH,
Graf-Arco-Strasse 3, 89079 Ulm,
DE
|
| (54) | REMODELING AND GLYCOPEGYLATION OF FIBROBLAST GROWTH FACTOR (FGF) |
| REMODELING AND GLYCOPEGYLATION OF FIBROBLAST GROWTH FACTOR (FGF) |